# US 2021/0330244 A1 · Compositions and methods for determining receptivity of an endometrium for embryonic implantation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0330244 A1
- Document ID: US20210330244A1
- Status: Published application
- Kind: A1
- Application number: 17/146,619
- Filed: 2021-01-12
- Published: 2021-10-28
- Earliest claimed: 2017-02-02
- Assignees: CooperSurgical, Inc.
- Applicants: CooperSurgical, Inc.
- Inventors: Santiago Munne; Joson A. Horcajadas; Jon Aizpurua
- Web page: https://patentgrep.com/patent/US20210330244A1

## CPC

- A61B 5/4325: {of the uterine cavities, e.g. uterus, fallopian tubes, ovaries}
- B01L 3/502753: {characterised by bulk separation arrangements on lab-on-a-chip devices, e.g. for filtration or centrifugation}
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 1/6883: for diseases caused by alterations of genetic material
- G01N 33/5023: {on expression patterns}
- G01N 33/689: {related to pregnancy or the gonads}
- G16H 10/40: for data related to laboratory analysis, e.g. patient specimen analysis
- G16H 50/30: for calculating health indices; for individual health risk assessment
- G16H 50/70: for mining of medical data, e.g. analysing previous cases of other patients
- A61B 5/4343: {Pregnancy and labour monitoring, e.g. for labour onset detection}
- A61B 5/7275: {Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor}
- B01L 2300/0819: Microarrays; Biochips
- C07K 14/59: Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
- C12Q 2600/112: Disease subtyping, staging or classification
- C12Q 2600/158: Expression markers
- G16H 20/10: relating to drugs or medications, e.g. for ensuring correct administration to patients
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

Provided herein are methods and kits for determining receptivity status of an endometrium for embryonic implantation.

## Claims

### Claim at position 1

1-24 (canceled)

### Claim 25

A kit comprising: reagents suitable for determining an endometrial gene expression profile of a panel of genes, wherein the panel of genes consists of: ANXA4, CATSPERB, PTGFR, PTGS1, IL8, SCGB2A2, ANGPTL1, HPRT1, MMP10, PGR, ITGA8, IFNG, PROK1, FOXO1, CXCL1, STC1, MMP9, MUC1, RPL13A, CALCA, ITGA9, RACGAP1, GPX3, PPP2R2C, ARG2, SCGB3A1, ALDH1A3, APOD, C2CD4B, TFF3, AQP3, GJA4, ARHGDIA, SELL, APOL2, MT1H, MT1X, MT1L, MAOA and MT1F in a biological sample obtained from a subject.

### Claim 26 (depends on 25)

The kit of claim 25, wherein the biological sample is an endometrial biopsy obtained from the uterine fundus.

### Claim 27 (depends on 25)

The kit of claim 25, wherein the reagents are suitable for reverse transcription polymerase chain reaction.

### Claim 28 (depends on 25)

The kit of claim 25, further comprising a chip, an array, a multi-well plate or a tube.

### Claim 29 (depends on 1, 25)

The kit of claim 25, further comprising instructions for use of the kit according to claim 1.
